Indrayani Biotech Limited was incorporated in 1992. The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers strawberries tissue culture plantlets and hybrid ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated the India Baby Food Market size at USD 1.68 billion in 2023. During the forecast period between ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare.

Late last year, doc­tors in­ject­ed an ex­per­i­men­tal CRISPR ther­a­py in­to the brain of a 9-year-old boy with a rare neu­rode­vel­op­men­tal con­di­tion that can cause in­tel ...

Medicamen Biotech, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹480.95. The stock has experienced fluctuations today ...

The new company is led by CEO Caroline Loew, a biotech veteran with experience at Blympse Bio, Bristol-Myers Squibb, and Merck. Mural Oncology has offices in Dublin, Ireland, but its primary ...

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes and Mr. Sunil Srinivasan Chari who are both career-technocrats ...

Listen to Story Reshma Kewalramani named in TIME magazine's 100 Most Influential People 2025 First woman to lead a major US biotech firm in 2020 Vertex got FDA approval for CRISPR-based therapy under ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against ...

I often refer to Regeneron as a “Biotech Juggernaut” because it seems like they have similar strengths to the comic book character. The company appears to have unstoppable momentum thanks to a ...

However, biotech companies have not given up on finding a treatment for HIV. The biotech industry has made progress in both treatment and prevention, and heavyweights like Gilead, ViiV Healthcare, and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...